2024年10月8日，杜克大学Nicholas S Heaton携手mRNA诺奖得主Drew Weissman在《Nature Communications》杂志上发表题为“Improved influenza vaccine responses ...

Jefferies sees Arbutus (ABUS) potentially benefitting from vaccines being developed by Moderna (MRNA) and Pfizer (PFE)/GSK ...

COVID-19 (omicron JN.1) vaccine is under clinical development by Moderna and currently in Pre-Registration for Coronavirus Disease 2019 (COVID-19).

The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

MRNA-1273.213 is under clinical development by Moderna and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

Five years after the virus that causes COVID emerged in China it still holds some mysteries. The disease has killed an ...

Biontech SE agreed to pay up to nearly $1.26 billion in two separate settlements to resolve royalty disputes with the U.S. NIH and the University of Pennsylvania related to the COVID-19 vaccine the ...

Pfizer's Comirnaty and Moderna's Spikevax vaccines are currently the 2 types of vaccines offered in the UK. They are both mRNA vaccines and have been updated to provide slightly higher levels of ...

Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor suppression and metastasis reduction. AI integration promises to ...

The vaccine will reportedly be used to treat cancer patients rather than given to the public to prevent cancer. Andrey Kaprin, the General Director of the Radiology Medical Research Centre of the ...

Russia announced that it is planning to complete the development of an mRNA cancer vaccine and launch it in 2025. "Russia has developed its own mRNA vaccine against cancer, it will be distributed to ...